Agustin Melian

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jeannette Potts, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Agustin Melian:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allovir, Inc. Chief Medical Officer Common Stock 453,529 $304,227 $0.6708 04 Oct 2021 Direct
Forma Therapeutics Holdings, Inc. EVP, Research & Development Common Stock 0 $5.05 14 Oct 2022 Direct
Forma Therapeutics Holdings, Inc. EVP, Research & Development Stock Option (Right to Buy) 0 14 Oct 2022 Direct

Insider Reports Filed by Agustin Melian

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924322033653-melian-agustin-2022-10-14 Forma Therapeutics Holdings, Inc. 14 Oct 2022 2 $0 4 EVP, Research & Development 14 Oct 2022, 16:06
/report/000089924322025976-melian-agustin-2022-07-11 Forma Therapeutics Holdings, Inc. 11 Jul 2022 2 $0 4 EVP, Research & Development 12 Jul 2022, 16:24
/report/000089924322025975-melian-agustin-2022-07-11 Forma Therapeutics Holdings, Inc. 11 Jul 2022 0 $0 3 EVP, Research & Development 12 Jul 2022, 16:23
KLRS Allovir, Inc. 04 Oct 2021 4 -$446,862 4 Chief Medical Officer 05 Oct 2021, 21:05
KLRS Allovir, Inc. 28 Sep 2021 1 -$90,432 4 Chief Medical Officer 29 Sep 2021, 16:15
KLRS Allovir, Inc. 05 Apr 2021 4 -$896,685 4 Chief Medical Officer 20 Sep 2021, 16:05